(Circulation. 1995;92:45-49.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Surgery (J. Pym, P.B., M.P.) and the Department of Medicine (J. Parker), Queen's University, Ontario, Canada.
Correspondence to Dr John Pym, Richardson House, 102 Stuart St, Kingston, Ontario, Canada K7L 2V6.
| Abstract |
|---|
|
|
|---|
Methods and Results We have now performed this operation in 126 patients (111 of whom were men) aged 32 to 78 years. The right gastroepiploic artery was used as a pedicle graft to the right main coronary artery in 25 patients, to its posterior descending branch in 90, to a left ventricular branch in 2, to branches of the circumflex system in 6, and to the left anterior descending artery in 1. Free (aortocoronary) gastroepiploic grafts were placed to circumflex branches in 2 patients. There were 2 hospital deaths (stroke, arrhythmia), and mean±SD postoperative stay was 7.5±2.0 days. All survivors were symptomatically improved and are functionally in New York Heart Association functional class I or II. There have been 3 late deaths (at 34, 50, and 84 months) in 2 to 120 months of follow-up (mean, 41.4 months). Angiography of bypass grafts and coronary arteries was performed in 44 patients at 7 days to 80 months postoperatively, providing direct evidence of gastroepiploic graft patency in 34 patients and strong indirect evidence in another 6; adequate data could not be obtained in 3 patients for technical reasons, and 1 graft was occluded.
Conclusions These short-term, intermediate, and long-term results demonstrate the suitability of the right gastroepiploic artery as a CABG. The use of the right gastroepiploic artery as a graft to coronary arteries on the posterior wall of the heart, in conjunction with one or both internal mammary arteries, has the potential to allow complete myocardial revascularization with viable arterial grafts.
Key Words: grafting revascularization arteries coronary disease
| Introduction |
|---|
|
|
|---|
The right GEA, a branch of the gastroduodenal artery, was used in the era of indirect myocardial revascularization as a Vineberg-type implant.13 14 In 1987, we reported its first use (June, 1984) as a direct CABG.15 Others have adopted the technique16 17 18 19 20 21 22 and have confirmed our encouraging early results.
| Methods |
|---|
|
|
|---|
Indications for the use of the GEA evolved during the series. During the first 2 years, the GEA was used in nine patients in whom there was insufficient long or short saphenous vein of adequate quality or extensive disease of the ascending aorta. Subsequently, the indications have been extended to include younger patients with accelerated atherosclerosis, where poor results with vein grafts can be predicted.23 In particular, we have considered some patients to have coronary anatomy particularly suitable for complete arterial revascularization, severe proximal stenosis or occlusion of coronary arteries within reach of, and compatible in size with, pedicled IMA and GEA grafts. Contraindications to its use included previous gastric surgery, morbid obesity, and advanced patient age, unless no other conduit was available. Where possible, we also avoided the use of multiple arterial grafts in patients with unstable angina that could not be medically stabilized before surgery.
Operative Technique
Through a minimally extended median
sternotomy incision, the GEA
was identified by palpation and the pedicle mobilized from the midpoint
of the greater curvature of the stomach back to the level of the
pylorus. The omental border was dissected with low intensity
electrocautery, and the few significant arterial and venous
branches were clipped or ligated. Gastric branches were individually
clipped (or ligated) after careful dissection of surrounding tissue,
thus allowing considerable elongation of the pedicle. Since the vast
majority of branches from the GEA are to the stomach, the resulting row
of clips or ligatures along one edge provided an easy means of
orientating the pedicle later in the procedure, to avoid twisting.
After systemic heparinization, all arterial grafts were
divided distally, and flow was assessed. They were occluded distally
with an atraumatic clamp to allow continued perfusion of the pedicle
and wrapped in gauze soaked with dilute papaverine hydrochloride
solution. Additional pharmacological dilatation with intraluminal
nitroglycerin or papaverine was rarely used.
The GEA pedicle was routed
either anterior or posterior to the pylorus,
depending on which appeared to be the more direct approach, and then
brought loosely through a cruciate incision in the diaphragm adjacent
to the atrioventricular groove. The pedicle then lay
parallel to the atrioventricular groove, ready for
grafting to the right coronary artery, its posterior descending
or left ventricular (LV) branches, or to distal circumflex
branches (Fig 1
).
|
Standard techniques of cardiopulmonary bypass were used, with systemic hypothermia to 27°C to 34°C depending on the number of grafts to be performed. Cold blood cardioplegic arrest was used in all but the first 21 patients. Spontaneous hypothermic ventricular fibrillation and local coronary occlusion were used in 1 patient whose ascending aorta could not be safely cross-clamped.
Coronary anastomoses for both IMA and GEA grafts were performed with the aid of x3.5 optical magnification, using an open technique with continuous 7-0 or 8-0 Prolene suture at both the heel and toe of the graft. Graft pedicles were anchored to the epicardium adjacent to the anastomosis with interrupted 5-0 Prolene sutures to prevent anastomotic twisting or tension.
The size of the GEA at the site of the distal anastomosis ranged from 1.25 to 2.5 mm and was usually just under 1.5 mm in internal diameter. Early in the series, free flow was recorded and ranged from 60 to 120 mL/min, comparable with the IMA.
The GEA was used to graft the
distal main right coronary artery
in 25 patients, its inferior LV branch in 2 patients, the
posterior descending artery in 90 patients, branches of the circumflex
system in 8 patients (2 as a free aortocoronary graft), and
the LAD in 1 patient. All but 2 patients had pedicled GEA bypass
grafts. Additional grafts were placed in 122 patients, a mean of 2.9
(range, 1 to 5) grafts per patient. One hundred and twenty-three
vessels were grafted with the left IMA, and there were 75 right IMA
grafts, but only 19 saphenous vein grafts were used. Graft distribution
is detailed in the Table
.
|
| Results |
|---|
|
|
|---|
Late Results
The 124 hospital survivors have been followed
for 2 to 120 months
after operation (mean, 41.4 months). Twenty-nine patients have been
followed for more than 5 years, and 49 for more than 4 years. Only 1
has been lost to follow-up. There have been 3 late deaths, at 34
months (cardiac), 50 months (pulmonary embolus), and 84 months
(probably noncardiac). Fig 2
shows an actuarial survival
curve for the group of 124 patients. All patients were
symptomatically improved after the operation and are in
NYHA functional class I or II. There have been no long-term
complications related to the use of the right GEA. One patient has
required laparotomy for abdominal aortic aneurysm resection,
and another has undergone laparoscopic cholecystectomy, both without
incident.
|
Graft Patency
Forty-four patients (37%) have undergone graft
and
coronary angiography at postoperative intervals from 7 days to
81 months (mean, 10.6 months). The first 8 patients were restudied
before hospital discharge, but resource limitations have not allowed a
more extensive elective angiographic follow-up program to date.
GEA
grafts were opacified by techniques ranging from semiselective
celiac axis flush to selective gastroduodenal
catheterization. Patency was clearly demonstrated in 35
GEA grafts and was strongly implied by native coronary
angiography in a further 6 patients. In these cases, the grafted
vessel, which had previously filled from collaterals, was
"missing," and there was no change in regional wall motion. In 3
patients, direct or indirect evidence of graft patency could not be
obtained for purely technical reasons. Only 1 GEA graft was
demonstrated to be occluded. All 4 GEA grafts studied more than 5 years
postoperatively were patent. Fig 3
shows a patent GEA
graft to the right coronary artery in patient No. 1 at 81
months, filling a markedly irregular right coronary system. Fig
4
shows a patent GEA graft to the posterior descending
artery in patient No. 21 at 63 months.
|
|
| Discussion |
|---|
|
|
|---|
The GEA, a branch of the gastroduodenal artery (usually arising from the right hepatic and celiac axis), is an artery that appears, like the IMA, to be relatively free of atherosclerosis.16 25 It was used in the Vineberg era for indirect myocardial revascularization,13 with demonstrated short-term angiographic patency.14 Like the long-term patency seen in IMA implants, 16- to 18-year angiographic patency has been seen in the occasional right GEA implant studied (G.M. FitzGibbon, National Defence Medical Centre, Ottawa, personal communication, 1993).
When appropriately harvested, the GEA can reach all arteries on the
posterior and posterolateral walls of the heart as a pedicle or in situ
graft. Previous nongastric abdominal surgery is not a contraindication
to its use provided that adhesions are not too dense to allow complete
mobilization of the pedicle. Technically, the GEA is particularly
suitable as a graft to the posterior descending artery, which is
usually relatively free of atherosclerotic disease (compared with the
main right coronary artery), and provides an excellent size
match. With experience, harvesting the GEA pedicle takes no longer than
harvesting the IMA (and is often quicker). Although the distal
anastomosis can be technically demanding, it is not usually more
difficult than an IMA-todistal circumflex graft. Our technical
strategy for complete arterial
revascularization reflects a strong bias toward
pedicled rather than free grafts. Thus, the GEA was used mostly as a
graft to the posterior coronary circulation (Table
). The left
IMA was most often grafted to the LAD and the right to the circumflex
system, usually through the transverse sinus of the pericardium. An
obvious advantage to this approach is the absence of a graft crossing
the midline anteriorly. Less frequently, the left IMA was used for a
distal circumflex branch, especially on a large heart, and when the GEA
had been used for the posterior descending artery. In these cases, the
left IMA was brought into the pericardium either just anterior or
posterior to the left phrenic nerve, and the right IMA was taken
anteriorly across to the LAD.
Although the small laparotomy and gastric manipulation requires postoperative nasogastric tube drainage, occasionally for several days, overall postoperative stay has not been prolonged. Lytle et al's early experience,18 where one third of the patients required hospitalization for more than 10 days, probably reflected their patient population (25% reoperations). In our experience, patients have been a little slow in initial mobilization but catch up rapidly without the discomfort of leg incisions. We have been impressed with the lack of short-term and long-term complications related to use of the GEA. Indeed, in two-vessel disease, particularly in diabetics, use of the GEA and one IMA may avoid the increased morbidity of bilateral IMA harvesting.
While two of our patients have undergone subsequent abdominal surgery without incident, GEA bypass grafts are clearly at risk of inadvertent damage during upper abdominal surgery, whether routed anterior or posterior to the stomach. Both the patients and their physicians should be educated about the use of this conduit. We believe that if its presence is known the GEA graft should be readily palpable and damage therefore avoidable. Apart from the concept of total arterial revascularization, which may be most relevant in a younger age group, there are patients whose coronary anatomies are suitable for primary or reoperative bypass surgery but who have inadequate conventional conduits, saphenous vein or IMA. Short-term results of other alternative conduits have been quite poor.9 10 11 12 Although free radial artery grafts are being reappraised, their long-term fate, like that of inferior epigastric grafts, is unknown. On the other hand, we believe that the use of the GEA as an alternative coronary bypass graft is now well established.
Angiography of GEA bypass grafts can be technically difficult, particularly since specialized catheters were not available early in our experience. Graft patency in our study was consistent with that reported by others.21 22 It should be noted that all four of our GEA grafts studied more than 5 years postoperatively were patent. In one of these patients, obvious progression of distal atherosclerosis was seen in two coronary systems but not in the GEA or IMA grafts.
We also noted catheter-induced spasm in several cases that was readily relieved by administration of intraluminal nitroglycerin. Indeed, while the GEA appears to be pharmacologically similar to the IMA,26 27 it is significantly more muscular. In unpublished data from our institution, ring segments of GEA developed nearly three times the grams force tension compared with IMA segments of the same size (K. Nakatsu, J. Pym, S. Witte; unpublished data). Thus, whether or not it is inherently more prone to develop spasm, the GEA is likely to be more vulnerable to the effects of spasm. Because of this, as much as the additional pre-bypass time, we have been reluctant to use the GEA or indeed more than one arterial graft in highly unstable patients unless satisfactory venous conduit was unavailable. It remains to be seen whether intraluminal treatment with, for example, newer calcium channel blockers may prevent perioperative spasm.
In conclusion, our short-term, intermediate, and long-term results demonstrate the continuing suitability of the right GEA as a conduit for CABG surgery. The use of the right GEA as a graft to coronary arteries on the posterior wall of the heart in conjunction with one or both IMAs has the potential to allow complete myocardial revascularization with viable arterial grafts.
| Selected Abbreviations and Acronyms |
|---|
|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. L. Quigley, S. J. Weiss, R. Y. Highbloom, and J. Pym Creative arterial bypass grafting can be performed on the beating heart Ann. Thorac. Surg., September 1, 2001; 72(3): 793 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ochi, N. Hatori, M. Fujii, Y. Saji, S. Tanaka, and H. Honma Limited flow capacity of the right gastroepiploic artery graft: postoperative echocardiographic and angiographic evaluation Ann. Thorac. Surg., April 1, 2001; 71(4): 1210 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tavilla, N. H.J. Pijls, K. H. Peels, and E. Berreklouw Noninvasive assessment of coronary flow reserve in the right gastroepiploic artery graft Ann. Thorac. Surg., December 1, 2000; 70(6): 2040 - 2044. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yasuura, Y. Takagi, Y. Ohara, Y. Takami, A. Matsuura, and H. Okamoto Theoretical analysis of right gastroepiploic artery grafting to right coronary artery Ann. Thorac. Surg., March 1, 2000; 69(3): 728 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Fonger, J. R. Doty, J. D. Salazar, P. L. Walinsky, and N. W. Salomon Initial experience with MIDCAB grafting using the gastroepiploic artery Ann. Thorac. Surg., August 1, 1999; 68(2): 431 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Voutilainen, K. Verkkala, A. Jarvinen, M. Kaarne, P. Keto, P. Voutilainen, and S. Mattila Minimally Invasive Coronary Artery Bypass Grafting Using the Right Gastroepiploic Artery Ann. Thorac. Surg., February 1, 1998; 65(2): 444 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. M. van Son, F. M. Smedts, C.-Q. Yang, M. Mravunac, V. Falk, F. W. Mohr, and G.-W. He Morphometric Study of the Right Gastroepiploic and Inferior Epigastric Arteries Ann. Thorac. Surg., March 1, 1997; 63(3): 709 - 715. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |